Introduction of RadioMatrix™: Stratasys Ltd. has announced the full commercial availability of its RadioMatrix™ radiopaque 3D printing material in the U.S., enabling healthcare providers and researchers to create patient-specific models for advanced medical imaging and training.
Capabilities and Validation: The material allows for precise control of radiopacity, with research from Siemens Healthineers validating its effectiveness in replicating human tissue in CT imaging, thus enhancing device testing and education.
Impact on Medical Training: Collaborations in the UK are already demonstrating the practical benefits of radiopaque 3D-printed models, improving imaging-based training and providing more controlled environments for research.
Advancements in Imaging Education: Stratasys aims to replace traditional phantom solutions and cadaver reliance with customizable, repeatable, and scalable alternatives, significantly enhancing the training and education of radiologists.
Wall Street analysts forecast SSYS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SSYS is 13.17 USD with a low forecast of 12.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast SSYS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SSYS is 13.17 USD with a low forecast of 12.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 11.500
Low
12.00
Averages
13.17
High
14.00
Current: 11.500
Low
12.00
Averages
13.17
High
14.00
Cantor Fitzgerald
Troy Jensen
Overweight
maintain
$13
2025-11-14
Reason
Cantor Fitzgerald
Troy Jensen
Price Target
$13
AI Analysis
2025-11-14
maintain
Overweight
Reason
Cantor Fitzgerald analyst Troy Jensen raised the firm's price target on Stratasys to $13.50 from $13 and keeps an Overweight rating on the shares. Stratasys posted results that were largely in-line with expectations as the topline continues to reflect macro-driven capital equipment spending constraint, while tariffs placed downward pressure on gross margins, the analyst tells investors in a research note.
Needham
James Ricchiuti
Strong Buy
Maintains
$12 → $13
2025-03-06
Reason
Needham
James Ricchiuti
Price Target
$12 → $13
2025-03-06
Maintains
Strong Buy
Reason
Cantor Fitzgerald
Troy Jensen
Buy
Maintains
$12 → $15
2025-03-04
Reason
Cantor Fitzgerald
Troy Jensen
Price Target
$12 → $15
2025-03-04
Maintains
Buy
Reason
Cantor Fitzgerald raised the firm's price target on Stratasys (SSYS) to $15 from $12 and keeps an Overweight rating on the shares ahead of the Q4 results on Wednesday. The company's preannouncement included Q4 revenue and profitability that comfortably exceeded forecasts, with an "industry-leading" 9%+ EBITDA margin, the analyst tells investors in a research note. The firm anticipates a cautiously optimistic revenue outlook for 2025, likely to be up low-single digits on a year over year basis. Cantor also wonders whether Desktop Metal (DM) is back on its acquisition radar, or possibly an acquisition of Nano Dimension (NNDM) now that the board is being run by activist-appointed professionals.
Needham
James Ricchiuti
Strong Buy
Reiterates
$12
2025-02-03
Reason
Needham
James Ricchiuti
Price Target
$12
2025-02-03
Reiterates
Strong Buy
Reason
About SSYS
Stratasys Ltd. provides polymer-based 3D printing solutions for industries such as aerospace, automotive, consumer products and healthcare. The Company's solutions consist of 3D printing systems, consumables, software, paid parts, and professional services and encompass everything from prototyping and design all the way through production. Its printers include F3300, FDM Fortus 450mc, PolyJet J3 DentaJet, P3 DLP Origin One Dental, SLA Neo, PolyJet J5 Digital Anatomy, and Powder Bed Fusion SAF H350. The Company's technologies include FDM Technology, PolyJet Technology, P3 DLP Technology, SAF Technology, Stereolithography Technology and 3DFashion Technology. Its FDM 3D printing technology has the ability to use a variety of production grade thermoplastic materials featuring surface resolution, chemical and heat resistance, color, and mechanical properties necessary for production of functional prototypes and parts for a variety of industries with specific demands and requirements.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
